Case number 1:22-cv-00220
Boehringer Ingelheim Pharmaceuticals Inc. et al v. Laurus Labs Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| May 19, 2023 | 14 | CONSENT JUDGMENT (CASE CLOSED) Signed by Judge Colm F. Connolly on 5/18/2023. (nmf) (Entered: 05/19/2023) (4) |
| Apr 19, 2022 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:21-cv-01485-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1485-CFC ONLY. (nmf) |
| Apr 18, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER: Civil Action Nos. 21-1485, 21-1486, 21-1487, 21-1573, 21-1766 and 22-220 are consolidated for all purposes. All future filings shall be made in Lead Case No. 21-1485-CFC only. Ordered by Judge Colm F. Connolly on 4/18/2022. Associated Cases: 1:21-cv-01485-CFC et al.(nmf) |
| Apr 13, 2022 | N/A | Status Conference (0) Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf) |
| Apr 8, 2022 | 12 | Answer to Complaint (27) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against All Plaintiffs by Laurus Labs Ltd., Laurus Generics Inc..(Poff, Adam) |
| Apr 8, 2022 | 13 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Laurus Labs Ltd. for Laurus Generics Inc. filed by Laurus Generics Inc., Laurus Labs Ltd.. (Poff, Adam) |
| Apr 7, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (19 in 1:21-cv-01486-CFC, 29 in 1:21-cv-00530-CFC, 11 in 1:22-cv-00220-CFC, 21 in 1:21-cv-01766-CFC, 19 in 1:21-cv-01573-CFC, 19 in 1:21-cv-01485-CFC, 19 in 1:21-cv-01487-CFC) MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(kmd) |
| Apr 7, 2022 | 11 | Motion for Leave to Appear Pro Hac Vice (12) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan) |
| Apr 5, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER Re-Setting Hearings, Due to a conflict in the Court's schedule, the In-Person Status Conference to discuss the parties' letters is rescheduled for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Apr 1, 2022 | 10 | Order (4) Docket Text: ORDER, Setting Hearings: A Status Conference is set for 4/13/2022 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly to discuss the parties' letters. Signed by Judge Colm F. Connolly on 4/1/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf) |
| Mar 18, 2022 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Laurus Generics Inc. served on 3/18/2022, answer due 4/8/2022. (Dellinger, Megan) |
| Mar 18, 2022 | 9 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Laurus Labs Ltd. served on 3/18/2022, answer due 4/8/2022. (Dellinger, Megan) |
| Feb 23, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Feb 18, 2022 | 1 | Main Document (9) Docket Text: COMPLAINT filed against Laurus Generics Inc., Laurus Labs Ltd. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3807116.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(twk) |
| Feb 18, 2022 | 1 | Exhibit A (52) |
| Feb 18, 2022 | 1 | Civil Cover Sheet (1) |
| Feb 18, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Feb 18, 2022 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: January 3, 2022. Date of Expiration of Patent: April 3, 2034. Thirty Month Stay Deadline: Not Applicable. (twk) |
| Feb 18, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,090,323 B2. (twk) |
| Feb 18, 2022 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (twk) |
| Feb 18, 2022 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Laurus Generics Inc. on 2/18/2022. (twk) |
| Feb 18, 2022 | 7 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Laurus Labs Ltd. on 2/18/2022. (twk) |
| Feb 18, 2022 | 1 | Complaint* (1) |
